Effects of Nuclear Factor-κB Small Interfering RNA on posterior capsule opacification

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4707-4715

  Park, Hae Young Lopilly ^a   Kim, In Tae ^a   Lee, Kyung Min ^b   Choi, Jun Sub ^a   Park, Myung Ok ^c   Joo, Choun Ki ^a  

^a The Catholic University of Korea   (South Korea)

^b Chan's Eye Hospital   (South Korea)

^c Biopolymed Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P105; PROTEIN P50; SMALL INTERFERING RNA; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACT EXTRACTION; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; ENUCLEATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENS EPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; TISSUE SECTION; ANIMAL; CELL DIVISION; CELL MOTION; DISEASE MODEL; GENE THERAPY; GENETICS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; LENS CAPSULE; METABOLISM; METHODOLOGY; ORGAN CULTURE TECHNIQUE; PATHOLOGY; POSTOPERATIVE COMPLICATION; RABBIT; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CATARACT EXTRACTION; CELL DIVISION; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GENE THERAPY; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LENS CAPSULE, CRYSTALLINE; NF-KAPPA B P50 SUBUNIT; ORGAN CULTURE TECHNIQUES; POSTOPERATIVE COMPLICATIONS; RABBITS; RNA, SMALL INTERFERING; WOUND HEALING;

EID: 77957353607     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4984     Document Type: Article

References (60)

1. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol. 1992;37:73-116.
2. Nishi O. Posterior capsule opacification. Part I: experimental investigations. J Cataract Refract Surg. 1999;25:106-117.
3. Tetz MR, Nimsgern C. Posterior capsule opacification. Part 2: clinical findings. J Cataract Refract Surg. 1999;25:1662-1674.
4. Clark DS. Posterior capsule opacification. Curr Opin Ophthalmol. 2000;11:56-64.
5. Pandey SK, Apple DJ, Werner L, Maloof AJ, Milverton EJ. Posterior capsule opacification: a review of the aetiopathogenesis experimental and clinical studies and factors for prevention. Indian J Opthalmol. 2004;52:99-112.
6. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998;105:1213-1221.
7. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology. 1983;90:1548-1553.
8. Steven D. Posterior capsule opacification. Curr Opin Ophthalmol. 2006;17:45-53.
9. Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification. Arch Ophthalmol. 2009;127:555-562.
10. Cobo LM, Ohsawa E, Chandler D, Arguello R, George G. Pathogenesis of capsular opacification after extracapsular cataract extraction: an animal model. Ophthalmology. 1984;91:857-863.
11. Wormstone IM. Posterior capsule opacification: a cell biological perspective. Exp Eye Res. 2002;74:337-347.
12. Frezzotti R, Caporossi A, Mastrangelo D, et al. Pathogenesis of posterior capsular opacification. Part II. Histopathological and in vitro culture findings. J Cataract Refract Surg. 1990;16:353-360.
13. Kappelhof JP, Vrensen GF. The pathology of after-cataract: a minireview. Acta Ophthalmol Suppl. 1992;205:13-24.
14. Awasthi N, Wagner BJ. Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. Invest Ophthalmol Vis Sci. 2006; 47:4482-4489.
15. Wormstone IM, Liu CS, Rakic JM, Marcantonio JM, Vrensen GF, Duncan G. Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci. 1997;38:396-404.
16. Walker JL, Wolff IM, Zhang L, Menko AS. Activation of SRC kinases signals induction of posterior capsule opacification. Invest Ophthalmol Vis Sci. 2007;48:2214-2223.
17. Choi JS, Kim JA, Kim DH, et al. Failure to activate NF-B promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res. 2000;883:60-68.
18. Saliou C, Kitazawa M, McLaughlin L, et al. Antioxidants modulate acute solar ultraviolet radiation-induced NFkappa-B activation in a human keratinocyte cell line. Free Radic Biol Med. 1999;26:174-183.
19. Baldwin AS Jr. The NF-κB and 1kB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
20. DiDonato JA, Hayakawa M, Rothwarf DM, et al. A cytokine-responsive IkB kinase that activates the transcription factor NF-κB. Nature. 1997;388:548-554.
21. Lee SJ, Bae SW, Seomun Y, et al. The role of nuclear factor kappa B in lens epithelial cell proliferation using a capsular bag model. Ophthalmic Res. 2008;40:273-278.
22. Lee DH, Cho KS, Park SG, et al. Cellular death mediated by nuclear factor kappa B (NF-κB) translocation in cultured human lens epithelial cells after ultraviolet-B irradiation. J Cataract Refract Surg. 2005;31:614-619.
23. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapyinduced apoptosis: potentiation by inhibition of NF-κB. Science. 1996;274:784-787.
24. Regnier CH, Song HY, Gao X, et al. Identification and characterization of an IkB kinase. Cell. 1997;90:373-383.
25. Verma IM, Stevenson JK, Schwarz EM, et al. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 1995;9: 2723-2735.
26. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-260.
27. Shishodia S, Aggarwal BB. Nuclear factor kappa B activation: a question of life or death. J Biochem Mol Biol. 2002:35;28-40.
28. Ren H, Schmalstieg A, Yuan D, Gaynor RB. I-kappa B kinase beta is critical for B cell proliferation and antibody response. J Immunol. 2002:168;577-587.
29. Kanegae Y, Tavares AT, Izpisua Belmonte JC, Verma IM. Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature. 1998;392:611-614.
30. Dejardin E, Bonizzi G, Bellahcene A, et al. Highly-expressed p100/ p52 (NF-κB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene. 1995;11:1835-1841.
31. Sovak MA, Bellas RE, Kim DW, et al. Aberrant nuclear factorkappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest. 1997;100:2952-2960.
32. Muller M, Morotti A, Ponzetto C. Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol. 2002;22:1060-1072.
33. Finco TS, Westwick JK, Norris JL, et al. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem. 1997;272:24113-24116.
34. Makarov SS. NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today. 2000;6:441-448.
35. Karin M. NF-κB and cancer: mechanisms and targets. Mol Carcinogen. 2006;45:355-361.
36. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol. 2002;727:725-734.
37. Sarkar FH, Li Y, Wang Z, Kong D. NF-B signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol. 2008;27:293-319.
38. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:624-655.
39. Lehner B, Fraser AG, Sanderson CM. Technique review: how to use RNA interference. Brief Funct Genomic Proteomic. 2004;3: 68-83.
40. Silverman N, Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2007;15:2321-2342.
41. Bender L, Spalton DJ, Uyanonvara B, et al. POCOman: new system for quantifying posterior capsule opacification. J Cataract Refract Surg. 2004;30:2058-2063.
42. Kim SY, Kim JH, Choi JS, et al. Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. Clin Exp Ophthalmol. 2007;35:755-758.
43. Gimbel HV. Posterior continuous curvilinear capsulorhexis and optic capture of the intraocular lens to prevent secondary opacification in pediatric cataract surgery. J Cataract Refract Surg. 1997;23:652-656.
44. Nishi O, Nishi K, Sakanishi K. Inhibition of migrating lens epithelial cells at the capsular bend created by the rectangular optic edge of a posterior chamber intraocular lens. Ophthalmic Surg Lasers. 1998;29:587-594.
45. Haus CM, Galand AL. Mitomycin against posterior capsular opacification: an experimental study in rabbits. Br J Ophthalmol. 1996;80:1087-1091.
46. Ismail MM, Alió JL, Ruiz Moreno JM. Prevention of secondary cataract by antimitotic drugs: experimental study. Ophthalmic Res. 1996;28:64-69.
47. Humphry RC, Davies EG, Jacob TJC, Thompson GM. The human anterior lens capsule: an attempted chemical debridement of epithelial cells by ethylenediaminetetraacetic acid (EDTA) and trypsin. Br J Ophthalmol. 1988;72:406-408.
48. Nishi O, Nishi K, Hikida M. Removal of lens epithelial cells following loosening of the junctional complex. J Cataract Refract Surg. 1993;19:56-61.
49. Nishi O, Nishi K, Mano C, et al. Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: a preliminary report. J Cataract Refract Surg. 1997;23:860-865.
50. Nishi O, Nishi K, Saitoh I, Sakanishi K. Inhibition of migrating lens epithelial cells by sustained release of ethylenediaminetetraacetic acid. J Cataract Refract Surg. 1996;22:863-868.
51. Nishi O, Nishi K, Fujiwara T, et al. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. Br J Ophthalmol. 1996;80:63-68.
52. Nishi O, Nishi K, Ohmoto Y. Synthesis of interleukin-1, interleukin- 6, and basic fibroblast growth factor by human cataract lens epithelial cells. J Cataract Refract Surg. 1996;22:852-858.
53. Totan Y, Yag R, Erdurmus M, et al. Cyclosporin effectively inhibits posterior capsule opacification after phacoemulsification in rabbits: a preliminary study. Clin Exp Ophthalmol. 2008;36:62-66.
54. Zelenka PS, Arpitha P. Coordinating cell proliferation and migration in the lens and cornea. Cell Dev Biol. 2008;19:113-124.
55. Iyengar L, Patkunanathan B, Lynch OT, McAvoy JW, Rasko JE, Lovicu FJ. Aqueous humour- and growth factor-induced lens cell proliferation is dependent on MAPK/ERK1/2 and Akt/PI3-K signalling. Exp Eye Res. 2006;83:667-678.
56. De Iongh RU, Gordon-Thomson C, Chamberlain CG, Hales AM, McAvoy JW. Tgfbeta receptor expression in lens: implications for differentiation and cataractogenesis. Exp Eye Res. 2001;72:649-659.
57. Beebe D, Garcia C, Wang X, et al. Contributions by members of the TGFbeta superfamily to lens development. Int J Dev Biol. 2004; 48:845-856.
58. De Iongh RU, Lovicu FJ, Overbeek PA, et al. Requirement for TGFbeta receptor signaling during terminal lens fiber differentiation. Development. 2001;128:3995-4010.
59. Hodgkinson LM, Duncan G, Wang L, Pennington CJ, Edwards DR, Wormstone IM. MMP and TIMP expression in quiescent, dividing, and differentiating human lens cells. Invest Ophthalmol Vis Sci. 2007;48:4192-4199.
60. Awasthi N, Wang-Su UT, Wagner BJ. Downregulation of MMP-2 and -9 by proteasone inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification. Invest Ophthalmol Vis Sci. 2008;49:1998-2003.